NIFTY  8,926.90  0.21%
  SENSEX  28,864.70  0.36%
 CURRENCY  Rs  66.93/$ 70.86/€, 83.36/£
  GOLD  29,211.00  -0.31%
  SILVER  42,669.00  -0.39%
  DAX  11,998.60  0.26%
  FTSE  7,302.25  0.38%
  CAC  4,895.88  0.12%
  HANG SENG  24,202.00  0.99%
  NIKKEI  19,379.90  -0.01%
  Shanghai Composite  3,261.22  0.14%
  DOW JONES  20,743.00  0.58%
  NASDAQ  5,865.95  0.47%
  S&P 500  2,365.38  0.60%
RBI GOVERNOR - Sufficient Flexibility To Move Policy Rate In Either Direction RBI GOVERNOR - Shift In Stance To Help Ensure That Inflation Brought Closer To 4% Aim

Ranbaxy Q4 Revenues May Rise By 6%

Video:

Play this video

February 5: Pharma major Ranbaxy is expected to announce its fourth quarter earnings today. For the quarter ended December 31, the company’s net profit is seen at Rs. 115 crore versus a loss of Rs. 492 crore. This time the Street will actually be watching beyond the basic numbers and focusing more on the management’s commentary in terms of the company’s efforts to resolve U.S. FDA issues. Agam Vakil shares more details on the same.